Effect of melatonin on sleep quality and EEG features in childhood epilepsy: a possible non-conventional treatment.
EEG
antiseizure medication
epilepsy
melatonin
sleep disorders
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
06
2023
accepted:
23
08
2023
medline:
2
10
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
epublish
Résumé
Sleep and epilepsy are characterized by a bidirectional relationship. Indeed, epilepsy predisposes to the development of sleep disorders, while sleep deprivation may exacerbate epilepsy. In addition, antiseizure medication can disrupt normal sleep architecture. Therefore, adequate sleep hygiene could lead to improvement in seizure control. The present study aimed to evaluate the effect of melatonin on seizure frequency, EEG tracing, and sleep in children with focal idiopathic epilepsy. This observation study evaluated the effect of 4 mg oral melatonin in ameliorating sleep-wake cycle, seizure frequency, and EEG features in children with focal idiopathic epilepsy of infancy. Twenty children were enrolled from September 2020 to August 2021. The study consisted of serial controls at enrollment (t0), at 3 months (t1), and at 6 months (t2) including neurological examination, questionnaire about sleep disturbances (CSHQ), and EEG. A significant improvement in sleep quality and daytime sleepiness was observed after melatonin supplementation. Furthermore, we observed a noteworthy improvement in EEG tracing at t2 that exhibited a significant correlation with improvements in CSHQ scores. The studies conducted so far to evaluate the effect of melatonin in persons with epilepsy do not lead to definitive conclusions. Despite the small population sample and the study design, we report sleep and EEG improvement after melatonin administration in our cohort. Larger studies are needed to further study the neuroprotective and anticonvulsant properties of melatonin.
Sections du résumé
Background
UNASSIGNED
Sleep and epilepsy are characterized by a bidirectional relationship. Indeed, epilepsy predisposes to the development of sleep disorders, while sleep deprivation may exacerbate epilepsy. In addition, antiseizure medication can disrupt normal sleep architecture. Therefore, adequate sleep hygiene could lead to improvement in seizure control. The present study aimed to evaluate the effect of melatonin on seizure frequency, EEG tracing, and sleep in children with focal idiopathic epilepsy.
Methods
UNASSIGNED
This observation study evaluated the effect of 4 mg oral melatonin in ameliorating sleep-wake cycle, seizure frequency, and EEG features in children with focal idiopathic epilepsy of infancy. Twenty children were enrolled from September 2020 to August 2021. The study consisted of serial controls at enrollment (t0), at 3 months (t1), and at 6 months (t2) including neurological examination, questionnaire about sleep disturbances (CSHQ), and EEG.
Results
UNASSIGNED
A significant improvement in sleep quality and daytime sleepiness was observed after melatonin supplementation. Furthermore, we observed a noteworthy improvement in EEG tracing at t2 that exhibited a significant correlation with improvements in CSHQ scores.
Conclusion
UNASSIGNED
The studies conducted so far to evaluate the effect of melatonin in persons with epilepsy do not lead to definitive conclusions. Despite the small population sample and the study design, we report sleep and EEG improvement after melatonin administration in our cohort. Larger studies are needed to further study the neuroprotective and anticonvulsant properties of melatonin.
Identifiants
pubmed: 37780697
doi: 10.3389/fneur.2023.1243917
pmc: PMC10538564
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1243917Informations de copyright
Copyright © 2023 Dell'Isola, Tascini, Vinti, Tulli, Dini, Mencaroni, Ferrara, Di Cara, Striano and Verrotti.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Pineal Res. 1997 Sep;23(2):97-105
pubmed: 9392448
J Child Neurol. 1998 Oct;13(10):501-9
pubmed: 9796757
Epilepsy Behav. 2010 Nov;19(3):197-203
pubmed: 20797913
Clin Neurophysiol. 2000 Sep;111 Suppl 2:S115-9
pubmed: 10996564
J Child Neurol. 2012 Dec;27(12):1524-8
pubmed: 22378657
J Pineal Res. 1998 May;24(4):215-8
pubmed: 9572530
Pediatr Neurol. 2019 Dec;101:33-38
pubmed: 31521449
Iran J Child Neurol. 2014 Summer;8(3):24-9
pubmed: 25143770
Front Neurol. 2022 Mar 01;13:817195
pubmed: 35299616
Rev Neurol (Paris). 2020 Mar;176(3):148-165
pubmed: 31718830
Brain Res. 2014 Apr 4;1557:34-42
pubmed: 24560601
Sleep. 2000 Dec 15;23(8):1043-51
pubmed: 11145319
Epilepsy Res. 2013 Dec;107(3):217-23
pubmed: 24206906
Curr Neuropharmacol. 2017 Apr;15(3):434-443
pubmed: 28503116
Dev Med Child Neurol. 2002 May;44(5):339-44
pubmed: 12033720
Behav Brain Res. 2016 Jul 1;307:199-207
pubmed: 27016427
Int J Neurosci. 1992 Mar;63(1-2):125-35
pubmed: 1342024
J Biol Chem. 1960 Jul;235:1992-7
pubmed: 14415935
Rev Neurol (Paris). 2021 Mar;177(3):245-259
pubmed: 32921425
Brain Res. 2006 Jul 12;1099(1):183-8
pubmed: 16764841
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
J Child Neurol. 2005 Jan;20(1):78-80
pubmed: 15791928
Neurology. 1977 Jun;27(6):567-70
pubmed: 559266
Neuropsychiatr Dis Treat. 2017 Jul 10;13:1797-1803
pubmed: 28744129
Lancet. 1998 Apr 25;351(9111):1254
pubmed: 9643754
Arch Dis Child. 2005 Nov;90(11):1203
pubmed: 16243887
Neuropediatrics. 2007 Jun;38(3):122-5
pubmed: 17985260
Epilepsy Behav. 2011 Apr;20(4):607-12
pubmed: 21454134
Methods Find Exp Clin Pharmacol. 2004 Mar;26(2):99-102
pubmed: 15071607
Eur J Clin Pharmacol. 2015 Aug;71(8):901-9
pubmed: 26008214
J Physiol Pharmacol. 2006 Nov;57 Suppl 5:19-39
pubmed: 17218758
Epilepsy Behav. 2020 Nov;112:107345
pubmed: 32861898
Epilepsy Behav. 2006 May;8(3):542-6
pubmed: 16524783
Sleep Med. 2015 May;16(5):637-44
pubmed: 25862116
Brain Dev. 2004 Sep;26(6):373-6
pubmed: 15275698
Neurology. 2000 Dec 12;55(11):1746-8
pubmed: 11113238
Sleep Med Clin. 2016 Mar;11(1):25-38
pubmed: 26972031
J Pineal Res. 1996 Mar;20(2):79-83
pubmed: 8815191
Cochrane Database Syst Rev. 2016 Aug 11;(8):CD006967
pubmed: 27513702
Biol Signals Recept. 1999 Jan-Apr;8(1-2):105-10
pubmed: 10085471
Pediatr Neurol. 2016 Apr;57:51-5
pubmed: 26851993
Adv Med Sci. 2007;52:11-28
pubmed: 18217386
Epilepsia. 2001 Sep;42(9):1208-10
pubmed: 11580772
J Formos Med Assoc. 2012 Feb;111(2):57-66
pubmed: 22370283
Neurochem Int. 1994 Feb;24(2):101-46
pubmed: 8161940
J Pineal Res. 2011 Mar;50(2):192-6
pubmed: 21044144